Dr. Reddy''s Laboratories Ltd.

By 2 December  1999 | 02 Dec 1999

1
  • Commercial Paper Programme- Rs. 500 million Rating :  P1+(Reaffirmed)

The ''P1+'' (pronounced P one plus) rating assigned to the Rs. 500 million Commercial Paper Programme of Dr. Reddy’s Laboratories Limited (DRL) has been reaffirmed.

DRL’s rating reflects the consolidation of its brands in chosen therapeutic segments both in domestic and export markets, diversified market & therapeutic presence, research driven integrated operations (two new molecules have entered phase II of clinical trials) and strong financial position with robust cash flows. The rating takes into account the product concentration risk and volatility in earnings in the company''s bulk product portfolio.

In the first half ended September 1999, the company registered a net profit of Rs 307 million on gross sales of Rs 2397 million.

 

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers